| ²é¿´: 708 | »Ø¸´: 4 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
xiaohezi7844½ûÑÔ (ÖªÃû×÷¼Ò)
|
[½»Á÷]
FDA08ÄêÅú×¼µÄÒ©Æ·
|
||
|
FDA08ÄêÒ»ÔÂÅú×¼µÄÒ©Æ·£¨ÉÏ£© ÉêÇëºÅ »îÐÔ³É·Ö ¹«Ë¾ Åú×¼ÀàÐÍ Åú×¼ÈÕ ¼ÁÐÍ ÊÊÓ¦Ö¢ NDA # 021924 LEVOTHYROXINE SODIUM¼××´ÏÙËØÄÆ INST BIOCHIMIQUE Supplement 01/01/2008 ½ºÄÒ ¼××´ÏÙ¹¦Äܲ»×㲡£¬´¹ÏÙTSHÒÖÖÆ NDA # 018031 HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDEÇâÂÈàçàº/ÑÎËáÆÕÝÁÂå¶û WYETH PHARMS INC Labeling Revision 01/02/2008 Ƭ¼Á ¸ßѪѹ NDA # 020356 NISOLDIPINEÄáË÷µØÆ½ SCIELE PHARMA INC Formulation Revision 01/02/2008 ½ºÄÒ¼Á£¨ER£© ¸ßѪѹ NDA # 021438 PROPRANOLOL HYDROCHLORIDEÑÎËáÆÕÝÁÂå¶û RELIANT PHARMS Labeling Revision 01/02/2008 Ƭ¼Á£¨ER£© ¸ßѪѹ NDA # 022044 METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATEÑÎËá¶þ¼×Ë«ëÒÁ×ËáÎ÷ËûÁÐÍ¡ MERCK Labeling Revision 01/02/2008 Ƭ¼Á 2ÐÍÌÇÄò²¡ NDA # 020375 ESTRADIOL´Æ¶þ´¼ BAYER HLTHCARE Labeling Revision 01/03/2008 Ĥ¼Á£¨ER£© ´Æ¼¤ËØ NDA # 020522 SOMATROPIN RECOMBINANT»ùÒòÖØ×éÈËÉú³¤¼¤ËØ GENENTECH Manufacturing Change or Addition 01/03/2008 ×¢Éä¼Á Éú³¤ËØ ANDA # 077963 GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ˾Çí TEVA PARENTERAL Approval 01/03/2008 ×¢Éä¼Á »¯ÁÆÖ¹Í ANDA # 078596 METFORMIN HYDROCHLORIDEÑÎËá¶þ¼×Ë«ëÒ INTERPHARM Approval 01/03/2008 Ƭ¼Á£¨ER£© ½µÌÇÒ© ANDA # 077643 TOPIRAMATE HYDROCHLORIDEÑÎËáÍÐßÁõ¥ COBALT Tentative Approval 01/04/2008 Ƭ¼Á ¿¹ñ²ðïÒ© ANDA # 078769 IBUPROFEN; OXYCODONE HYDROCHLORIDE²¼Âå·ÒÑÎËáôÇ¿¼Íª ACTAVIS ELIZABETH Approval 01/04/2008 Ƭ¼Á ÕòÍ´Ò© NDA # 050207 ERYTHROMYCIN ETHYLSUCCINATEçúÒÒºìÃ¹ËØ ABBOTT Labeling Revision 01/05/2008 ¿ÅÁ£¼Á ¿¹ÉúËØ NDA # 050611 ERYTHROMYCINºìÃ¹ËØ ABBOTT Labeling Revision 01/05/2008 Ƭ¼Á£¬°üÒ¿ÅÁ£ ¿¹ÉúËØ NDA # 021368 TADALAFILËû´ïÄÇ·Ç LILLY New Dosage Regimen 01/07/2008 Ƭ¼Á ÐÔ²ªÆð¹¦ÄÜÕϰ ANDA # 065434 CEFDINIRÍ·æßµØÄá AUROBINDO PHARMA Approval 01/07/2008 ½ºÄÒ¼Á ¿¹ÉúËØ ANDA # 077062 FENTANYL·ÒÌ«Äá ABRIKA PHARMS Control Supplement 01/07/2008 Ĥ¼Á£¨ER£© ÕòÍ´Ò© ANDA # 078151 TERBUTALINE SULFATEÁòËáÌØ²¼ËûÁÖ AKORN Approval 01/07/2008 ×¢Éä¼Á ƽ´Ò© NDA # 017963 METOPROLOL TARTRATE¾ÆÊ¯ËáÃÀÍÐÂå¶û NOVARTIS Labeling Revision 01/08/2008 Ƭ¼Á ¸ßѪѹ NDA # 018303 HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATEÇâÂÈàç຾ÆÊ¯ËáÃÀÍÐÂå¶û NOVARTIS Labeling Revision 01/08/2008 Ƭ¼Á ¸ßѪѹ NDA # 019649 RIMANTADINE HYDROCHLORIDEÑÎËá½ð¸ÕÒÒ°· FOREST LABS Labeling Revision 01/08/2008 Ƭ¼Á ¿¹²¡¶¾ ANDA # 077129 RIVASTIGMINE TARTRATE¾ÆÊ¯ËῨ°ÍÀÍ¡ WATSON LABS Approval 01/08/2008 ½ºÄÒ¼Á ¿¹ADÒ© ANDA # 077297 GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ˾Çí SICOR PHARMS Tentative Approval 01/08/2008 ×¢Éä¼Á »¯ÁÆÖ¹Í ANDA # 077917 PRAVASTATIN SODIUM ÆÕ·¥ËûÍ¡ÄÆ LUPIN PHARMS Approval 01/08/2008 ½ºÄÒ¼Á ¸ß֬Ѫ֢ ANDA # 078090 GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ˾Çí ABRAXIS PHARM Tentative Approval 01/08/2008 ×¢Éä¼Á »¯ÁÆÖ¹Í ANDA # 078403 SERTRALINE HYDROCHLORIDEÑÎËáÉáÇúÁÖ WOCKHARDT Approval 01/08/2008 Ƭ¼Á ¿¹ÒÖÓôÒ© NDA # 021490 ETHINYL ESTRADIOL; NORETHINDRONEȲ´Æ´¼È²ÅµÍª WARNER CHILCOTT Labeling Revision 01/09/2008 ¾×½ÀƬ ±ÜÔÐÒ© ANDA # 040094 ACETAMINOPHEN; HYDROCODONE BITARTRATE¶ÔÒÒõ£°±»ù·Ó+ÖØ¾ÆÊ¯Ëá¿É´ýÒòͪ WATSON LABS Supplier Addition 01/09/2008 Ƭ¼Á ÕòÍ´Ò© ANDA # 077051 FENTANYL·ÒÌ«Äá LAVIPHARM LABS Control Supplement 01/09/2008 Ĥ¼Á£¨ER£© ÕòÍ´Ò© ANDA # 076507 FLUCONAZOLE·ú¿µßò TARO Control Supplement 01/09/2008 Ƭ¼Á ¿¹¾úÒ© ANDA # 078339 GEMCITABINE¼ªÎ÷Ëû±ö HOSPIRA INC Tentative Approval 01/09/2008 ×¢Éä¼Á ¿¹Ö×ÁöÒ© NDA # 021610 OXYMORPHONE HYDROCHLORIDEÑÎËáôÇÂð·Èͪ ENDO PHARMS Control Supplement 01/10/2008 Ƭ¼Á£¨ER£© ÕòÍ´Ò© NDA # 021658 CICLESONIDE»·Ë÷Äε NYCOMED US INC Approval 01/10/2008 ÎüÈë¼Á ƽ´Ò© ANDA # 065342 CEFTRIAXONEÍ·æßÇúËÉ HIKMA FARMACEUTICA Approval 01/10/2008 ×¢Éä¼Á ¿¹ÉúËØ ANDA # 065372 POLYMYXIN B SULFATEÁòËá¶àÕ³¾úËØB ABRAXIS PHARM PRODS Approval 01/10/2008 ×¢Éä¼Á ¶àëÄÀ࿹ÉúËØ ANDA # 078213 PROPRANOLOL HYDROCHLORIDEÆÕÝÁÂå¶û NORTHSTAR HLTHCARE Approval 01/10/2008 Ƭ¼Á ¸ßѪѹ NDA # 021153 ESOMEPRAZOLE MAGNESIUM°£Ë÷ÃÀÀßòþ ASTRAZENECA Labeling Revision 01/11/2008 ½ºÄÒ£¨DR£© PPI NDA # 021773 EXENATIDE SYNTHETICÀà¸ßѪÌÇÒò×Ó AMYLIN Labeling Revision 01/11/2008 ×¢Éä¼Á ½µÌÇÒ© ANDA # 065305 CEFTRIAXONE SODIUMÍ·æßÇúËÉÄÆ LUITPOLD Approval 01/11/2008 ×¢Éä¼Á ¿¹ÉúËØ ANDA # 077344 DONEPEZIL HYDROCHLORIDEÑÎËá¶àÄÎß߯ë TEVA PHARMS Tentative Approval 01/11/2008 Ƭ¼Á ¿¹ADÒ© ANDA # 077620 GLIPIZIDE; METFORMIN HYDROCHLORIDEßÁàºË«ëÒÆ¬ CARACO Approval 01/11/2008 Ƭ¼Á ½µÌÇÒ© ANDA # 077631 CETIRIZINE HYDROCHLORIDEÑÎËáÎ÷ÌæÀûຠCARACO Approval 01/11/2008 Ƭ¼Á ¿¹¹ýÃôÒ© ANDA # 078069 OXCARBAZEPINE°Â¿¨Î÷ƽ BRECKENRIDGE PHARM Approval 01/11/2008 Ƭ¼Á ¿¹ñ²ðïÒ© NDA # 020998 CELECOXIBÈûÀ´Îô²¼ GD SEARLE Labeling Revision 01/14/2008 ½ºÄÒ¼Á ¹Ø½ÚÑ× NDA # 021083 SIROLIMUSÎ÷ÂÞĪ˾ WYETH PHARMS INC Efficacy Supplement with Clinical Data to Support 01/14/2008 ¿Ú·þÈÜÒº ÃâÒßÒÖÖÆ¼Á ANDA # 076273 CLOPIDOGREL BISULFATEÂÈßÁ¸ñÀ×ÁòËáÇâÑÎ DR REDDYS LABS INC Approval 01/14/2008 Ƭ¼Á ¿¹ÄýѪҩ ANDA # 078145 KETOROLAC TROMETHAMINEͪ¿©Ëá°±¶¡Èý´¼ LUITPOLD Approval 01/14/2008 ×¢Éä¼Á ֹʹҩ ANDA # 078198 GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ˾Çí APOTEX Tentative Approval 01/14/2008 ×¢Éä¼Á »¯ÁÆÖ¹Í BLA # 125104 NATALIZUMABÄÇËûÖéµ¥¿¹ BIOGEN IDEC Supplement 01/14/2008 ×¢Éä¼Á ¿¹Ö×ÁöÒ© 08ÄêÒ»ÔÂÅú×¼µÄÒ©Æ·£¨Ï£© NDA # 021350 FENOFIBRATE·Çŵ±´ÌØ SKYEPHARMA AG Labeling Revision 01/15/2008 Ƭ¼Á ¸ß֬Ѫ֢ ANDA # 077793 PRAVASTATIN SODIUMÆÕ·¥ËûÍ¡ÄÆ TEVA PHARMS Approval 01/15/2008 Ƭ¼Á ¸ß֬Ѫ֢ ANDA # 078343 CETIRIZINE HYDROCHLORIDEÑÎËáÎ÷ÌæÀûຠDR REDDYS LABS LTD Approval 01/15/2008 Ƭ¼Á ¿¹¹ýÃôÒ© ANDA # 078662 DONEPEZIL HYDROCHLORIDEÑÎËá¶àÄÎß߯ë ROXANE Tentative Approval 01/15/2008 Ƭ¼Á ¿¹ADÒ© NDA # 021071 ROSIGLITAZONE MALEATEÂíÀ´ËáÂÞ¸ñÁÐͪ SB PHARMCO Labeling Revision 01/16/2008 Ƭ¼Á ½µÌÇÒ© NDA # 021426 SOMATROPIN RECOMBINANT»ùÒòÖØ×éÈËÉú³¤¼¤ËØ SANDOZ Formulation Revision 01/16/2008 ×¢Éä¼Á Éú³¤ËØ ANDA # 077570 FLUTICASONE PROPIONATE±ûËá·úÌæ¿¨ËÉ HI TECH PHARMA Approval 01/16/2008 ÆøÎí¼Á ÌÇÆ¤Öʼ¤ËØ ANDA # 078143 FLUOXETINE HYDROCHLORIDEÑÎËá·úÎ÷Í¡ WOCKHARDT Approval 01/16/2008 ½ºÄÒ¼Á ¿¹ÒÖÓôÒ© ANDA # 078477 AMLODIPINE BESYLATE±½»ÇËá°±ÂÈµØÆ½ INTERPHARM Approval 01/16/2008 Ƭ¼Á ¸ßѪѹ ANDA # 078598 CIPROFLOXACIN HYDROCHLORIDEÑÎËá»·±ûɳÐÇ PHARMAFORCE Approval 01/16/2008 µÎ¼Á ¿¹ÉúËØ NDA # 021087 OSELTAMIVIR PHOSPHATEÁ×Ëá°Â˾ËûΤ ROCHE Labeling Revision 01/17/2008 »ìÐüÒº ¿¹²¡¶¾Ò© NDA # 021471 AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE°¢ÎÖ±½ËÉ/ÒÀÝ¨Êæ/°Â¿ËÁ¢ÁÖ/¶þÑõ»¯îÑ LOREAL USA Labeling Revision 01/17/2008 Èé¸à ·Àɹ¼Á NDA # 022067 PREDNISOLONE ACETATE´×ËáÆÃÄáËÉÁú TARO Approval 01/17/2008 »ìÐüÒº ÌÇÆ¤Öʼ¤ËØ ANDA # 076740 NIMODIPINEÄáĪµØÆ½ BANNER PHARMACAPS Approval 01/17/2008 ½ºÄÒ ¸ßѪѹ NDA # 019537 CIPROFLOXACIN HYDROCHLORIDEÑÎËá»·±ûɳÐÇ BAYER PHARMS Labeling Revision 01/18/2008 Ƭ¼Á ¿¹ÉúËØ NDA # 020780 CIPROFLOXACIN »·±ûɳÐÇ BAYER PHARMS Labeling Revision 01/18/2008 »ìÐüÒº ¿¹ÉúËØ NDA # 021176 COLESEVELAM HYDROCHLORIDEÑÎËῼÀ´Î¬ÂØ DAIICHI SANKYO New or Modified Indication 01/18/2008 Ƭ¼Á ½µÌÇÒ© NDA # 021180 ETHINYL ESTRADIOL; NORELGESTROMINÒÒȲ´Æ¶þ´¼/¼×»ùÔÐͪ ORTHO MCNEIL PHARM Labeling Revision 01/18/2008 Ĥ¼Á£¨ER£© ±ÜÔÐÒ© NDA # 021229 OMEPRAZOLE MAGNESIUM°ÂÃÀÀßòþ ASTRAZENECA Labeling Revision 01/18/2008 Ƭ¼Á£¨ER£© PPI NDA # 021473 CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE»·±ûɳÐÇ£¬ÑÎËá»·±ûɳÐÇ BAYER PHARMS Labeling Revision 01/18/2008 Ƭ¼Á£¨ER£© ¿¹ÉúËØ NDA # 022107 ALISKIREN HYDROCHLOROTHIAZIDE°¢Àû¼ªÂØ/ÇâÂÈàçຠNOVARTIS PHARMS Approval 01/18/2008 Ƭ¼Á ¸ßѪѹ NDA # 022187 ETRAVIRINEÒÁËûΤ¶÷ TIBOTEC Approval 01/18/2008 Ƭ¼Á ¿¹²¡¶¾Ò© ANDA # 077255 LANSOPRAZOLEÀ¼Ë÷Àßò TEVA PHARMS Tentative Approval 01/18/2008 ½ºÄÒ¼Á£¨DR£© PPI BLA # 103792 TRASTUZUMABÇúÍ×Öéµ¥¿¹ GENENTECH Supplement 01/18/2008 ×¢Éä¼Á ¿¹Ö×ÁöÒ© BLA # 125057 ADALIMUMAB°¢´ïľµ¥¿¹ ABBOTT Supplement 01/18/2008 ×¢Éä¼Á ¹Ø½ÚÑס¢ÒøÐ¼²¡µÈ NDA # 017628 TOLMETIN SODIUMÍжûÃ×Í¡ÄÆ ORTHO MCNEIL PHARM Labeling Revision 01/22/2008 ½ºÄÒ¼Á NSAID NDA # 021506 MICAFUNGIN SODIUMÃ׿¨·Ò¾»ÄÆ ASTELLAS New or Modified Indication 01/22/2008 ×¢Éä¼Á ¿¹¾úÒ© NDA # 050580 AZTREONAM°±ÇúÄÏ BRISTOL MYERS SQUIBB Labeling Revision 01/22/2008 ×¢Éä¼Á ¿¹ÉúËØ NDA # 021538 SOMATROPIN rDNA ORIGINALÈËÉú³¤¼¤ËØÔʼrDNA CANGENE CORP Approval 01/23/2008 ×¢Éä¼Á Éú³¤ËØ NDA # 050813 AMOXICILLIN°¢ÄªÎ÷ÁÖ MIDDLEBROOK PHARMA Approval 01/23/2008 Ƭ¼Á£¨ER£© ¿¹ÉúËØ ANDA # 077453 OXYTOCINËõ¹¬ËØ TEVA PARENTERAL Approval 01/24/2008 ×¢Éä¼Á Òý²ú¡¢²úºó³öѪµÈ BLA # 103705 RITUXIMABÀûÍ×Îôµ¥¿¹ GENENTECH Supplement 01/24/2008 ×¢Éä¼Á ¿¹Ö×ÁöÒ© NDA # 018827 BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE¶þ±ûËá±¶ËûÃ×ËÉ¿Ëùßò SCHERING Labeling Revision 01/25/2008 Èé¸à ¿¹¾úÒ© NDA # 020010 BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE¶þ±ûËá±¶ËûÃ×ËÉ¿Ëùßò SCHERING PLOUGH RES Labeling Revision 01/25/2008 Ï´Òº ¿¹¾úÒ© NDA # 021166 ESTRADIOL´Æ¶þ´¼ ASCEND Labeling Revision 01/25/2008 Äý½º¼Á ´Æ¼¤ËØ NDA # 022023 FOSAPREPITANT DIMEGLUMINE°¢ÈðßÁ̹¶þ¼×ÆÏ°· MERCK CO INC Approval 01/25/2008 ·ÛÄ©¼Á Ö¹ÍÂÒ© ANDA # 040517 METHADONE HYDROCHLORIDEÑÎËáÃÀɳͪ MALLINCKRODT Control Supplement 01/26/2008 Ƭ¼Á Õò¾²¼Á ANDA # 040545 ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE¶ÔÒÒõ£°±»ù·Ó/ÑÎËáôÇÇâ¿É´ýͪ MALLINCKRODT Control Supplement 01/26/2008 Ƭ¼Á Õò¾²¼Á ANDA # 075618 ACETAMINOPHEN/BUTALBITAL/CAFFEINE/CODEINE PHOSPHATE¶ÔÒÒõ£°±»ù·Ó,²¼Ëû±ÈÍ×,¿§·ÈÒò,Á×Ëá¿É´ýÒò WEST WARD Supplier Addition 01/26/2008 ½ºÄÒ¼Á Õò¾²¼Á ANDA # 087757 ACETAMINOPHEN; HYDROCODONE BITARTRATE¶ÔÒÒõ£°±»ù·Ó+ÖØ¾ÆÊ¯Ëá¿É´ýÒòͪ SCHWARZ PHARMA Control Supplement 01/26/2008 Ƭ¼Á ÕòÍ´Ò© NDA # 020639 QUETIAPINE FUMARATE¸»ÂíËá¿üÁòƽ ASTRAZENECA Labeling Revision 01/28/2008 Ƭ¼Á ¾«Éñ·ÖÁÑÖ¢ NDA # 022157 LEVOCETIRIZINE DIHYDROCHLORIDEÑÎËá×óÐýÎ÷ÌæÀûຠUCB INC Approval 01/28/2008 ¿Ú·þÈÜÒº ¿¹¹ýÃôÒ© ANDA # 040762 PHENDIMETRAZINE TARTRATE¾ÆÊ¯Ëá±½¼×ÇúÇØ AMIDE PHARM Approval 01/28/2008 Ƭ¼Á ·ÊÅÖÖ¢ ANDA # 040874 DIPYRIDAMOLE Ë«à×´ïĪ ZYDUS PHARMS USA INC Approval 01/28/2008 Ƭ¼Á ¿¹ÑªË¨ ANDA # 065185 BLEOMYCIN SULFATEÁòËᲩÀ´Ã¹ËØ ABRAXIS PHARM Approval 01/28/2008 ×¢Éä¼Á ¿¹Ö×Áö¿¹ÉúËØ NDA # 021476 ESZOPICLONEÓÒ×ôÆ¥¿Ë¡ SEPRACOR Labeling Revision 01/29/2008 Ƭ¼Á ʧÃß ANDA # 040776 DEXTROAMPHETAMINE SULFATEÓÒÐý±½±û°·ÁòËáÑÎ OUTLOOK PHARMS Approval 01/29/2008 ¿Ú·þÈÜÒº ·ÊÅÖÖ¢ ANDA # 077630 TAMSULOSIN HYDROCHLORIDEÑÎËá̹Ë÷ÂÞÐÁ TEVA PHARMS Tentative Approval 01/29/2008 ½ºÄÒ¼Á ǰÁÐÏÙ¼²²¡ ANDA # 078066 CALCITRIOL¹Ç»¯Èý´¼ AKORN Approval 01/29/2008 ×¢Éä¼Á άÉúËØÀàÒ© ANDA # 078242 TECHNETIUM TC-99M MEBROFENIN KITï½99¼×äå·ÆÄþÊÔ¼ÁºÐ CIS Approval 01/29/2008 ¡ª¡ª Õï¶ÏÓÃÒ© ANDA # 078850 LAMIVUDINEÀÃ×·ò¶¨ INVAGEN PHARMS Tentative Approval 01/29/2008 Ƭ¼Á ÒҸΠNDA # 020151 VENLAFAXINE HYDROCHLORIDEÑÎËáάÀ·¨ÐÁ WYETH PHARMS INC Labeling Revision 01/30/2008 Ƭ¼Á ¿¹ÒÖÓôÒ© NDA # 020699 VENLAFAXINE HYDROCHLORIDEÑÎËáάÀ·¨ÐÁ WYETH PHARMS INC Labeling Revision 01/30/2008 ½ºÄÒ¼Á£¨ER£© ¿¹ÒÖÓôÒ© ANDA # 040732 PHENYTOIN SODIUM±½Í×Ӣį WOCKHARDT USA Approval 01/30/2008 ½ºÄÒ¼Á ¿¹ñ²ðïÒ© ANDA # 077693 CALCIUM ACETATE´×Ëá¸Æ ROXANE Approval 01/30/2008 Ƭ¼Á ÓªÑø²¹³ä¼Á ANDA # 078075 BRIMONIDINE TARTRATE¾ÆÊ¯ËáäåĪÄᶨ SANDOZ Approval 01/30/2008 µÎÑÛÒº Çà¹âÑÛ ANDA # 078327 SUMATRIPTAN SUCCINATEÊæÂí̹çúçêËáÑÎ AUROBINDO PHARMA Tentative Approval 01/30/2008 Ƭ¼Á ƫͷʹ ANDA # 078725 GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ˾Çí MYLAN Approval 01/30/2008 ×¢Éä¼Á ¿¹Ö×ÁöÒ© NDA # 020683 ETHINYL ESTRADIOL; LEVONORGESTRELȲ´Æ´¼×óȲŵÔÐͪ WYETH PHARMS INC Labeling Revision 01/31/2008 Ƭ¼Á ±ÜÔÐÒ© NDA # 021437 EPLERENONEÒÀÆÕÀûͪ GD SEARLE LLC Patient Population Altered 01/31/2008 Ƭ¼Á ¸ßѪѹ NDA # 021928 VARENICLINE TARTRATE¾ÆÊ¯ËáÍßÂ×Äá¿ËÁÖ PFIZER INC Labeling Revision 01/31/2008 Ƭ¼Á ½äÑÌÒ© NDA # 022064 LEVOCETIRIZINE DIHYDROCHLORIDEÑÎËá×óÐýÎ÷ÌæÀûຠUCB INC Labeling Revision 01/31/2008 Ƭ¼Á ¿¹¹ýÃôÒ© ANDA # 077260 IRINOTECAN HYDROCHLORIDEÑÎËáÒÁÁ¢Ì濵 TEVA PARENTERAL Tentative Approval 01/31/2008 ×¢Éä¼Á ¿¹Ö×ÁöÒ© ANDA # 077760 PROPRANOLOL HYDROCHLORIDEÑÎËáÆÕÝÁÂå¶û HIKMA FARMACEUTICA Approval 01/31/2008 ×¢Éä¼Á ¸ßѪѹ ANDA # 078002 CAFFEINE CITRATEÄûÃÊËá¿§·ÈÒò ABRAXIS PHARM PRODS Approval 01/31/2008 ¿Ú·þÈÜÒº Ð˷ܼÁ ANDA # 078081 AMLODIPINE BESYLATE±½»ÇËá°±ÂÈµØÆ½ MUTUAL PHARMA Approval 01/31/2008 Ƭ¼Á ¸ßѪѹ ANDA # 078619 FLUOXETINE HYDROCHLORIDEÑÎËá·úÎ÷Í¡ AUROBINDO PHARMA Approval 01/31/2008 ½ºÄÒ¼Á ¿¹ÒÖÓôÒ© ANDA # 078626 SERTRALINE HYDROCHLORIDEÑÎËáÉáÇúÁÖ MATRIX LABS LTD Approval 01/31/2008 Ƭ¼Á ¿¹ÒÖÓôÒ© ANDA # 078787 GABAPENTIN¼Ó°ÍÅç¶¡ AUROBINDO PHARM Approval 01/31/2008 ½ºÄÒ¼Á ¿¹ñ²ðïÒ© [ Last edited by xiaohezi7844 on 2008-4-3 at 21:19 ] |
» ²ÂÄãϲ»¶
µ¼Ê¦ÏëÈÃÎÒ´Ó¶ÀÁ¢Ò»×÷±ä³ÉÁ˹²Ò»µÚÒ»
ÒѾÓÐ9È˻ظ´
²©Ê¿¶ÁÍêδÀ´Ò»¶¨»áºÃÂð
ÒѾÓÐ23È˻ظ´
µ½Ðµ¥Î»ºó£¬»»ÁËеÄÑо¿·½Ïò£¬Ã»ÓÐÍŶӣ¬³ÖÐø»ýÀÛ2ÇøÒÔÉÏÂÛÎÄ£¬ÄÜÉêÇëµ½ÃæÉÏÂð
ÒѾÓÐ11È˻ظ´
¶Á²©
ÒѾÓÐ4È˻ظ´
JMPT ÆÚ¿¯Í¶¸åÁ÷³Ì
ÒѾÓÐ4È˻ظ´
ÐÄÂöÊÜËð
ÒѾÓÐ5È˻ظ´
SpringerÆÚ¿¯Í¶¸åÇóÖú
ÒѾÓÐ4È˻ظ´
СÂÛÎÄͶ¸å
ÒѾÓÐ3È˻ظ´
ÉêÇë2026Ä격ʿ
ÒѾÓÐ6È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
xiaohezi7844
½ûÑÔ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ¹ó±ö: 0.7
- ½ð±Ò: 13254.2
- É¢½ð: 275
- ºì»¨: 54
- ɳ·¢: 26
- Ìû×Ó: 8605
- ÔÚÏß: 266.7Сʱ
- ³æºÅ: 120405
- ×¢²á: 2005-11-29
- רҵ: Ò©ÎïÉè¼ÆÓëÒ©ÎïÐÅÏ¢
|
FDA08Äê¶þÔÂÅú×¼µÄÒ©Æ·£¨ÉÏ£© NDA # 020564 LAMIVUDINEÀÃ×·ò¶¨ GLAXOSMITHKLINE Patient Population Altered 02/01/2008 Ƭ¼Á ÂýÒҸΠNDA # 007638 CHLORPHENIRAMINE MALEATEÂíÀ´ËáÂȱ½ÄÇÃô SCHERING PLOUGH Labeling Revision 02/04/2008 Ƭ¼Á£¨ER£© ¿¹¹ýÃôÒ© NDA # 017058 METHADONE HYDROCHLORIDEÑÎËáÃÀɳͪ ROXANE Labeling Revision 02/04/2008 Ƭ¼Á ½ä¶¾Ò© NDA # 017116 METHADONE HYDROCHLORIDEÑÎËáÃÀɳͪ MALLINCKRODT Labeling Revision 02/04/2008 ŨËõÒº ½ä¶¾Ò© NDA # 018063 NADOLOLÄɶàÂå¶û KING PHARMS Labeling Revision 02/04/2008 Ƭ¼Á ¸ßѪѹ NDA # 021272 TREPROSTINIL SODIUMÇúǰÁл·ËØÄÆ UNITED THERAP Labeling Revision 02/04/2008 ×¢Éä¼Á ·Î¶¯Âö¸ßѹ ANDA # 078785 ATAZANAVIR SULFATE°¢ÔúÄÇΤÁòËáÑÎ EMCURE PHARMA Tentative Approval 02/04/2008 ½ºÄÒ¼Á ¿¹²¡¶¾Ò© NDA # 021140 LOPERAMIDE HYDROCHLORIDE; SIMETHICONEÑÎËáÂåßß¶¡°·/¶þ¼×»ù¹èÓÍ MCNEIL CONS Labeling Revision 02/05/2008 Ƭ¼Á ֹкҩ NDA # 021266 VORICONAZOLE·üÁ¢¿µßò PFIZER Labeling Revision 02/05/2008 Ƭ¼Á ¿¹¾úÒ© NDA # 021514 METHYLPHENIDATEßß¼×õ¥ SHIRE Labeling Revision 02/05/2008 Ĥ¼Á£¨ER£© ADHD£¨¶à¶¯£© NDA # 021730 LEVALBUTEROL TARTRATE×óÐýɳ¶¡°·´¼¾ÆÊ¯ËáÑÎ SEPRACOR Control Supplement 02/05/2008 ÆøÎí¼Á Ö§Æø¹Ü¾·ÂÎ NDA # 021881 ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE¿¹»µÑªËá/¾ÛÒÒ¶þ´¼3350/ÂÈ»¯¼Ø/VCÄÆ/ÂÈ»¯ÄÆ/ÁòËáÄÆ SALIX PHARMS Labeling Revision 02/05/2008 ¿Ú·þÈÜÒº Ç峦 ANDA # 065323 CEFUROXIME AXETILÍ·æßß»ÐÁõ¥ RANBAXY Approval 02/05/2008 ¿Ú·þ»ìÐü¼Á ¿¹ÉúËØ ANDA # 077830 ESOMEPRAZOLE MAGNESIUM°£Ë÷ÃÀÀßòþ RANBAXY Tentative Approval 02/05/2008 ½ºÄÒ£¨DR£© PPI NDA # 017577 OXYBUTYNIN CHLORIDEÑÎËá°ÂÎô²¼Äþ ALZA Labeling Revision 02/06/2008 Ƭ¼Á °òë×Ñס¢ÄòµÀÑ× NDA # 020238 CIMETIDINE¼×ëæßä°· GLAXOSMITHKLINE Labeling Revision 02/06/2008 Ƭ¼Á ¿¹Î¸À£ÑñÒ© NDA # 050006 DOXYCYCLINE¶àÎ÷»·ËØ PFIZER Labeling Revision 02/06/2008 »ìÐü¼Á ¿¹ÉúËØ NDA # 050007 DOXYCYCLINE HYCLATEÑÎËá¶àÎ÷»·ËØ PFIZER Labeling Revision 02/06/2008 ½ºÄÒ¼Á ¿¹ÉúËØ NDA # 050480 DOXYCYCLINE CALCIUM¶àÎ÷»·ËØ¸Æ PFIZER Labeling Revision 02/06/2008 »ìÐü¼Á ¿¹ÉúËØ ANDA # 074681 FLUCONAZOLE·ú¿µßò TEVA Facility Addition 02/06/2008 Ƭ¼Á ¿¹¾úÒ© ANDA # 075710 ALENDRONATE SODIUM°¢ÂØì¢ËáÄÆ TEVA PHARMS Approval 02/06/2008 Ƭ¼Á ¿¹¹ÇÖÊÔöÉú ANDA # 075960 TRAMADOL HYDROCHLORIDEÑÎËáÇúÂí¶à ACTAVIS ELIZABETH Control Supplement 02/06/2008 Ƭ¼Á ÕòÍ´Ò© ANDA # 076184 ALENDRONATE SODIUM°¢ÂØì¢ËáÄÆ BARR Approval 02/06/2008 Ƭ¼Á ¿¹¹ÇÖÊÔöÉú ANDA # 077355 CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE·¨ÄªÌæ¶¡/̼Ëá¸Æ/ÇâÑõ»¯Ã¾ PERRIGO R AND D Approval 02/06/2008 Ƭ¼Á£¨¾×½À£© ¿¹Î¸À£ÑñÒ© ANDA # 077615 DIVALPROEX SODIUMË«±ûÎìËáÄÆ NU-PHARM, INC. Tentative Approval 02/06/2008 Ƭ¼Á£¨DR£© ¿¹ñ²ðïÒ© ANDA # 078031 DICLOFENAC SODIUMË«ÂÈ·ÒËáÄÆ ALCON Approval 02/06/2008 µÎÑÛ¼Á NSAID ANDA # 078290 DIVALPROEX SODIUMË«±ûÎìËáÄÆ SANDOZ Tentative Approval 02/06/2008 Ƭ¼Á£¨DR£© ¿¹ñ²ðïÒ© NDA # 019813 FENTANYL·ÒÌ«Äá ALZA Labeling Revision 02/07/2008 Ĥ¼Á£¨ER£© ÕòÍ´Ò© NDA # 020151 VENLAFAXINE HYDROCHLORIDEÑÎËáÎÄÀ·¨ÐÁ WYETH PHARMS INC Labeling Revision 02/07/2008 Ƭ¼Á ÒÖÓôÖ¢ NDA # 021445 EZETIMIBEÒÀÔóÌæÃ×±´ MSP SINGAPORE Labeling Revision 02/07/2008 Ƭ¼Á ½µÖ¬Ò© NDA # 021947 FENTANYL CITRATEÄûÃÊËá·ÒÌ«Äá CEPHALON Labeling Revision 02/07/2008 Ƭ¼Á ÕòÍ´Ò© NDA # 050582 DOXYCYCLINE HYCLATEÑÎËá¶àÎ÷»·ËØ MAYNE PHARMA INTL Labeling Revision 02/07/2008 ½ºÄÒ¼Á£¨DR£© ¿¹ÉúËØ ANDA # 077800 LEVALBUTEROL HYDROCHLORIDEÑÎËá×óÐýɳ¶¡°·´¼ DEY LP Tentative Approval 02/07/2008 ÈÜÒº¼Á Ö§Æø¹Ü¾·ÂÎ NDA # 020941 DOCOSANOL¶þÊ®¶þÍé´¼ GLAXOSMITHKLINE Manufacturing Change or Addition 02/08/2008 Èé¸à ¿Ú¡¢Á³²¿ðåÕî NDA # 021210 LEVOTHYROXINE SODIUM¼××´ÏÙËØÄÆ STEVENS J Formulation Revision 02/08/2008 Ƭ¼Á ¼××´ÏÙ¹¦ÄܼõÍËÖ¢ NDA # 021518 SOLIFENACIN SUCCINATEË÷·ÇÄÇÐÁ ASTELLAS Labeling Revision 02/08/2008 Ƭ¼Á °òë׶ද֢ NDA # 021687 EZETIMIBE; SIMVASTATINÒÀÔóÌæÃ×±´/ÐÁ·¥ËûÍ¡ MSP SINGAPORE Labeling Revision 02/08/2008 Ƭ¼Á ½µÖ¬Ò© ANDA # 040613 HOMATROPINE METHYLBROMIDE/HYDROCODONE BITARTRATEÖØ¾ÆÊ¯Ëá¶þÇâ¿É´ýÒòͪ/äå¼×ºóÂíÍÐÆ· HI TECH PHARMA Approval 02/08/2008 Ìǽ¬¼Á Âé×íÒ© NDA # 013055 ORPHENADRINE CITRATEèÛéÚËá°Â·ÒÄǾý GRACEWAY Labeling Revision 02/11/2008 ×¢Éä¼Á Âé×íÒ©/½â¾·Ò© NDA # 020151 VENLAFAXINE HYDROCHLORIDEÑÎËáÎÄÀ·¨ÐÁ WYETH PHARMS INC Labeling Revision 02/11/2008 ½ºÄÒ£¨»ºÊÍ£© ÒÖÓôÖ¢ ANDA # 065302 AZITHROMYCIN°¢ÆæÃ¹ËØ WOCKHARDT Approval 02/11/2008 Ƭ¼Á ¿¹ÉúËØ ANDA # 077491 PRAVASTATIN SODIUMÆÕ·¥ËûÍ¡ÄÆ LEK PHARMS DD Approval 02/11/2008 Ƭ¼Á ½µÖ¬Ò© ANDA # 077821 ACETAMINOPHEN; PROPOXYPHENE NAPSYLATEÎÞË®ÝÁ»ÇËáÓÒ±ûÑõ·Ò¡¢¶ÔÒÒõ£°±»ù·Ó CONCORD LABS NJ Approval 02/11/2008 Ƭ¼Á ÕòÍ´Ò© ANDA # 078371 FINASTERIDE·ÇÄÇÐÛ°· ACTAVIS TOTOWA Approval 02/11/2008 Ƭ¼Á ǰÁÐÏÙÔöÉú ANDA # 078391 HYDROCHLOROTHIAZIDEÇâÂÈàçຠCADISTA PHARMS Approval 02/11/2008 ½ºÄÒ¼Á ÀûÄò¼Á ANDA # 078575 BICALUTAMIDE±È¿¨Â³°· SANDOZ Tentative Approval 02/11/2008 Ƭ¼Á ǰÁÐÏÙ°© ANDA # 078597 DIVALPROEX SODIUMË«±ûÎìËáÄÆ SUN PHARM INDS LTD Tentative Approval 02/11/2008 Ƭ¼Á£¨DR£© ¿¹ñ²ðïÒ© NDA # 017892 TRIAZOLAMÈýßòÂØ PHARMACIA AND UPJOHN Labeling Revision 02/12/2008 Ƭ¼Á ´ßÃß¼Á ANDA # 040717 PRIMIDONEÆËÃ×ͪ IMPAX LABS Approval 02/12/2008 Ƭ¼Á ¿¹ñ²ðïÒ© ANDA # 040724 PROMETHAZINE HYDROCHLORIDEÑÎËáÒì±ûຠIMPAX LABS Approval 02/12/2008 Ƭ¼Á ¿¹¹ýÃôÒ© NDA # 020778 NELFINAVIR MESYLATE¼×»ÇÄηÇÄÇΤ AGOURON Labeling Revision 02/13/2008 ·ÛÄ©¼Á ¿¹°¬×ÌÒ© NDA # 021336 SELEGILINE˾À´¼ªÀ¼ SOMERSET Labeling Revision 02/13/2008 Ĥ¼Á£¨ER£© ÅÁ½ðÉÖ¢ ANDA # 078408 VINORELBINE TARTRATE ¾ÆÊ¯Ë᳤´ºÈð±õ EBEWE PHARMA Approval 02/13/2008 ×¢Éä¼Á ¿¹Ö×ÁöÒ© ANDA # 078678 GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ˾Çí ORCHID HLTHCARE Approval 02/13/2008 Ƭ¼Á »¯ÁÆÖ¹ÍÂÒ© NDA # 020683 ETHINYL ESTRADIOL; LEVONORGESTREL×óȲŵÔÐͪ/Ȳ´Æ´¼ WYETH PHARMS INC Labeling Revision 02/14/2008 Ƭ¼Á ±ÜÔÐÒ© NDA # 022081 AMBRISENTAN°²²©É̹ GILEAD Labeling Revision 02/14/2008 Ƭ¼Á ·Î¶¯Âö¸ßѹ ANDA # 040699 BENZTROPINE MESYLATE¼×»ÇËá±½ÔúÍÐÆ· ACTAVIS TOTOWA Approval 02/14/2008 Ƭ¼Á ÅÁ½ðÉÖ¢ ANDA # 078191 RAMIPRILÀ×ÃׯÕÀû DR REDDYS LABS LTD Tentative Approval 02/14/2008 ½ºÄÒ¼Á ¸ßѪѹ ANDA # 078409 LAMOTRIGINEÀĪÈýຠSANDOZ Tentative Approval 02/14/2008 Ƭ¼Á ¿¹ñ²ðïÒ© ANDA # 078692 CETIRIZINE HYDROCHLORIDEÑÎËáÎ÷ÌæÀûຠSANDOZ Approval 02/14/2008 ¾×½ÀƬ¼Á ¿¹¹ýÃôÒ© ANDA # 078922 ZIDOVUDINEÆë¶à·ò¶¨ MATRIX LABS LTD Approval 02/14/2008 Ƭ¼Á ÒҸΠNDA # 019962 METOPROLOL SUCCINATEçúçêËáÃÀÍÐÂå¶û ASTRAZENECA Control Supplement 02/15/2008 Ƭ¼Á£¨ER£© ¸ßѪѹ NDA # 021277 MOXIFLOXACIN HYDROCHLORIDEÑÎËáĪÎ÷ɳÐÇ BAYER PHARMS Labeling Revision 02/15/2008 Ƭ¼Á ¿¹ÉúËØ NDA # 021085 MOXIFLOXACIN HYDROCHLORIDEÑÎËáĪÎ÷ɳÐÇ BAYER PHARMS Labeling Revision 02/15/2008 ×¢Éä¼Á ¿¹ÉúËØ NDA # 021937 EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATEÒÀ·¨Î¤ÂØ/¶÷ÇúËû±õ/ÌæÅµ¸£Î¤õ¥ GILEAD Labeling Revision 02/15/2008 Ƭ¼Á ¿¹°¬×ÌÒ© NDA # 021985 ALISKIREN HEMIFUMARATE¸»ÂíËá°¢Àû¿ËÂØ NOVARTIS Labeling Revision 02/15/2008 Ƭ¼Á ¸ßѪѹ NDA # 022078 NIACIN/SIMVASTATINÑÌËáÐÁ·¥ËûÍ¡ ABBOTT Approval 02/15/2008 Ƭ¼Á ½µÖ¬Ò© NDA # 050781 MINOCYCLINE HYDROCHLORIDEÑÎËáÃ×ŵ»·ËØ ORAPHARMA Labeling Revision 02/15/2008 ·Û¼Á£¨ER£© ¿¹ÉúËØ ANDA # 065359 CEFUROXIME AXETILÍ·æßß»ÐÁõ¥ ORCHID HLTHCARE Approval 02/15/2008 Ƭ¼Á ¿¹ÉúËØ ANDA # 078688 BENDROFLUMETHIAZIDE; NADOLOLÜзúàçàº/ÄɶàÂå¶û MYLAN Approval 02/15/2008 Ƭ¼Á ¸ßѪѹ FDA08Äê¶þÔÂÅú×¼µÄÒ©Æ·£¨Ï£© (ANDA # 077724) PRAMIPEXOLE DIHYDROCHLORIDEÑÎËáÆÕÀ¿ËË÷ BARR Approval 02/19/2008Ƭ¼Á/ÅÁ½ðÉÖ¢ (NDA # 021548)FOSAMPRENAVIR CALCIUM¸£Ë¾°²ÆÕÄÇΤ¸Æ GLAXOSMITHKLINE Labeling Revision 02/20/2008/Ƭ¼Á/¿¹°¬×ÌÒ© (NDA # 021567)ATAZANAVIR SULFATE°¢ÔúÄÇΤÁòËáÑÎ BRISTOL MYERS SQUIBB Labeling Revision 02/20/2008½ºÄÒ/¿¹°¬×ÌÒ© (NDA # 021692) TRAMADOL HYDROCHLORIDEÑÎËáÇúÂí¶à BIOVAIL LABS INTL Labeling Revision 02/20/2008Ƭ¼Á£¨ER£©/ÕòÍ´Ò© (NDA # 022029)METHYL SALICYATE/MENTHOLË®ÑîËá¼×õ¥/±¡ºÉÄÔ HISAMITSU PHARM Approval 02/20/2008Ìù¼Á/ֹʹҩ (ANDA # 077219)IRINOTECAN HYDROCHLORIDEÑÎËáÒÁÁ¢Ì濵 WATSON LABS Approval 02/20/2008×¢Éä¼Á/¿¹Ö×ÁöÒ© (NDA # 016199) HYDROCORTISONEÇ⻯¿ÉµÄËÉ ANI PHARMS Labeling Revision 02/21/2008¹à³¦¼Á/À£ÑñÐԽ᳦Ñ× |
2Â¥2008-04-03 16:23:40
xiaohezi7844
½ûÑÔ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ¹ó±ö: 0.7
- ½ð±Ò: 13254.2
- É¢½ð: 275
- ºì»¨: 54
- ɳ·¢: 26
- Ìû×Ó: 8605
- ÔÚÏß: 266.7Сʱ
- ³æºÅ: 120405
- ×¢²á: 2005-11-29
- רҵ: Ò©ÎïÉè¼ÆÓëÒ©ÎïÐÅÏ¢
|
(NDA # 018771)HYDROXYPROPYL CELLULOSEôDZû»ùÏËÎ¬ËØ ATON Labeling Revision 02/21/2008ÑÛ²¿²åÈë¼Á/¸ÉÑÛ×ÛºÏÖ¢ (NDA # 021036) ZANAMIVIRÔúÄÇÃ×Τ GLAXOSMITHKLINE Labeling Revision 02/21/2008·Û¼Á/¿¹²¡¶¾Ò© (NDA # 022028) COSYNTROPINÌæ¿É¿ËëÄ SANDOZ Approval 02/21/2008×¢Éä¼Á/´ÙƤÖÊËØÀàÒ© (NDA # 050441) CLINDAMYCIN PHOSPHATE¿ËÁÖÃ¹ËØÁ×Ëáõ¥ PHARMACIA AND UPJOHN Labeling Revision 02/21/2008/×¢Éä¼Á/¿¹ÉúËØ (NDA # 050536)ERYTHROMYCINºìÃ¹ËØ HOSPIRA Labeling Revision 02/21/2008½ºÄÒ£¨DR£©¿¹ÉúËØ (NDA # 050547)CEFOTAXIME SODIUMÍ·æßàçë¿ÄÆ SANOFI AVENTIS US Labeling Revision 02/21/2008×¢Éä¼Á/¿¹ÉúËØ (ANDA # 065396)CEFADROXIL/CEFADROXIL HEMIHYDRATEÍ·æßôǰ±ÜÐ/°ëˮͷæßôǰ±ÜÐ LUPIN Approval 02/21/2008»ìÐü¼Á/¿¹ÉúËØ (ANDA # 078024) CIPROFLOXACIN; DEXTROSE»·±ûɳÐÇ/ÆÏÌÑÌÇ CLARIS LIFESCIENCES Tentative Approval 02/21/2008×¢Éä¼Á/¿¹ÉúËØ (BLA # 125057) ADALIMUMAB°¢´ïľµ¥¿¹ ABBOTT Supplement 02/21/2008×¢Éä¼Á/¹Ø½ÚÑ× (NDA # 021071) ROSIGLITAZONE MALEATEÂíÀ´ËáÂÞ¸ñÁÐͪ SB PHARMCO Labeling Revision 02/22/2008Ƭ¼Á/½µÌÇÒ© (NDA # 050794) AZACITIDINE°¢Ôú°ûÜÕ PHARMION Manufacturing Change or Addition 02/22/2008×¢Éä¼Á/¹ÇËèÔöÉúÒì³£×ÛºÏÕ÷ (BLA # 125085)BEVACIZUMAB±´·¥µ¥¿¹ GENENTECH Supplement 02/22/2008×¢Éä¼Á/¿¹Ö×ÁöÒ© (NDA # 018163) TEMAZEPAMÌæÂíÎ÷ãú TYCO HLTHCARE Labeling Revision 02/25/2008½ºÄÒ¼Á/´ßÃßÒ© (NDA # 020895)SILDENAFIL CITRATEÎ÷µØÄÇ·ÇÄûÃÊËáÑÎ PFIZER IRELAND Labeling Revision 02/25/2008Ƭ¼Á/¿¹EDÒ© (NDA # 021976) DARUNAVIR ETHANOLATEµØÈðÄÇΤ TIBOTEC Formulation Revision 02/25/2008Ƭ¼Á/¿¹°¬×ÌÒ© (ANDA # 077170)CERTIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDEÑÎËáÎ÷ÌæÀûàº/ÑÎËáαÂ黯¼î TEVA PHARMS Approval 02/25/2008Ƭ¼Á£¨ER£©¹ýÃôÐÔ±ÇÑ× (ANDA # 077234)AMIODARONE HYDROCHLORIDEÑÎËá°·µâͪ HIKMA FARMACEUTICA Approval 02/25/2008×¢Éä¼Á/¿¹ÐÄÂÉʧ³£Ò© (NDA # 021067) MOMETASONE FUROATE¿·ËáĪÃ×ËÉ SCHERING Labeling Revision 02/26/2008·Û¼Á/ƤÖʼ¤ËØ (NDA # 021813)ESTRADIOL´Æ¶þ´¼ BRADLEY PHARMS Package Change 02/26/2008Äý½º¼Á/´Æ¼¤ËØ (NDA # 022044) METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATEÁ×ËáÎ÷ËûÁÐÍ¡/ÑÎËá¶þ¼×Ë«ëÒ MERCK Efficacy Supplement with Clinical Data to Support 02/26/2008Ƭ¼Á/½µÌÇÒ© (NDA # 022057) PROGESTERONE»ÆÌåͪ FERRING Labeling Revision 02/26/2008Äý½º¼Á/Ôм¤ËØ (ANDA # 040814)CARBINOXAMINE MALEATEÂíÀ´ËῨ±ÈɳÃ÷ BOCA PHARMA Approval 02/26/2008¿Ú·þÈÜÒº/¿¹¹ýÃôÒ© (NDA # 050609) ERYTHROMYCIN LACTOBIONATEÈéÌÇËáºìÃ¹ËØ HOSPIRA Labeling Revision 02/26/2008×¢Éä¼Á/¿¹ÉúËØ (NDA # 050742) IVERMECTINÒÁά¾úËØ MERCK Manufacturing Change or Addition 02/26/2008Ƭ¼Á/¿¹ÉúËØ (ANDA # 077728)CALCIUM ACETATE´×Ëá¸Æ ROXANE Approval 02/26/2008½ºÄÒ/ÓªÑø²¹³ä¼Á (ANDA # 078058)ANASTROZOLE°¢ÄÇÇúßò TEVA PHARMS Tentative Approval 02/26/2008Ƭ¼Á/¿¹Ö×ÁöÒ© (ANDA # 078098) TECHNETIUM TC-99M SESTAMIBIï½TC-99M˾Ëû±È MALLINCKRODT Tentative Approval 02/26/2008×¢Éä¼Á/Õï¶ÏÊÔ¼Á (ANDA # 078155) SIMVASTATINÐÁ·¥ËûÍ¡ ACCORD HLTHCARE Approval 02/26/2008Ƭ¼Á/½µÖ¬Ò© (ANDA # 078478)TORSEMIDEÍÐÀÈûÃ× SUN PHARM INDS Approval 02/26/2008Ƭ¼Á/ÀûÄò¼Á (NDA # 021729) ARIPIPRAZOLE°¢Á¢ßßßò OTSUKA Patient Population Altered 02/27/2008×¢Éä¼Á/¾«Éñ·ÖÁÑÖ¢ (NDA # 022101)ESOMEPRAZOLE MAGNESIUM°£Ë÷ÃÀÀßò ASTRAZENECA Approval 02/27/2008»ìÐü¼Á/ppi (ANDA # 040797) MEPROBAMATE¼×±û°±õ¥ INVAGEN PHARMS Approval 02/27/2008Ƭ¼Á/¿¹½¹ÂÇÒ© (NDA # 050317) LINCOMYCIN HYDROCHLORIDEÑÎËáÁÖ¿ÉÃ¹ËØ PHARMACIA AND UPJOHN Labeling Revision 02/27/2008×¢Éä¼Á/¿¹ÉúËØ (NDA # 050435) CARBENICILLIN INDANYL SODIUMÜÐÜáÎ÷ÁÖÄÆ PFIZER Labeling Revision 02/27/2008Ƭ¼Á/¿¹ÉúËØ (ANDA # 065425)DEMECLOCYCLINE HYDROCHLORIDEÑÎËáÈ¥¼×½ðÃ¹ËØ AMNEAL PHARM Approval 02/27/2008Ƭ¼Á/¿¹ÉúËØ (ANDA # 077260)IRINOTECAN HYDROCHLORIDEÑÎËáÒÁÁ¢Ì濵 TEVA PARENTERAL Approval 02/27/2008×¢Éä¼Á/¿¹Ö×ÁöÒ© (ANDA # 077776)IRINOTECAN HYDROCHLORIDEÑÎËáÒÁÁ¢Ì濵 APP PHARMS Approval 02/27/2008×¢Éä¼Á/¿¹Ö×ÁöÒ© (ANDA # 077994)IRINOTECAN HYDROCHLORIDEÑÎËáÒÁÁ¢Ì濵 SANDOZ Approval 02/27/2008×¢Éä¼Á/¿¹Ö×ÁöÒ© (ANDA # 078037) GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ˾Çí CIPLA LIMITED Approval 02/27/2008Ƭ¼Á/¿¹Ö×ÁöÒ© (ANDA # 078188) IRINOTECAN HYDROCHLORIDEÑÎËáÒÁÁ¢Ì濵 DABUR ONCOLOGY PLC Approval 02/27/2008×¢Éä¼Á/¿¹Ö×ÁöÒ© (ANDA # 078224) AMLODIPINE BESYLATE±½»ÇËá°±ÂÈµØÆ½ MATRIX LABS Approval 02/27/2008Ƭ¼Á/¸ßѪѹ (ANDA # 078589)IRINOTECAN HYDROCHLORIDEÑÎËáÒÁÁ¢Ì濵 ACTAVIS TOTOWA Approval 02/27/2008×¢Éä¼Á/¿¹Ö×ÁöÒ© (ANDA # 078745)RAMIPRILÀ×ÃׯÕÀû INVAGEN PHARMS Tentative Approval 02/27/2008½ºÄÒ/¸ßѪѹ (ANDA # 078796)IRINOTECAN HYDROCHLORIDEÑÎËáÒÁÁ¢Ì濵 HOSPIRA Approval 02/27/2008×¢Éä¼Á/¿¹Ö×ÁöÒ© (ANDA # 078843)GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ˾Çí APOTEX INC Approval 02/27/2008Ƭ¼Á/Ö¹ÍÂÒ© (NDA # 019872) ACETAMINOPHEN¶ÔÒÒõ£°±»ù·Ó MCNEIL CONS Labeling Revision 02/28/2008Ƭ¼Á£¨ER£©½âÈÈÕòÍ´Ò© (NDA # 021318) TERIPARATIDE RECOMBINANT HUMANÈËÖØ×éÌØÁ¢ÅÁëÄ LILLY Labeling Revision 02/28/2008×¢Éä¼Á/¹ÇÖÊÊèËÉ (NDA # 021688) CINACALCET HYDROCHLORIDEÑÎËáÎ÷ÄÇ¿¨Èû AMGEN Labeling Revision 02/28/2008Ƭ¼Á/¼××´ÅÔÏÙ»úÄÜ¿º½øºÍ¸ß¸ÆÑªÖ¢ (NDA # 021937) EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATEÒÀ·¢Î¤ÂØ+¶÷ÇúËû±õ+ÌæÅµ¸£Î¤õ¥ GILEAD Labeling Revision 02/28/2008Ƭ¼Á/¿¹°¬×ÌÒ© (NDA # 022033) FLUVOXAMINE MALEATEÂíÀ´Ëá·ú·üɳÃ÷ SOLVAY PHARMS Approval 02/28/2008Ƭ¼Á£¨ER£©/¿¹ÒÖÓôÒ© (ANDA # 040751) IMIPRAMINE HYDROCHLORIDEÑÎËá±ûßäຠACTAVIS TOTOWA Approval 02/28/2008Ƭ¼Á/¿¹ÒÖÓôÒ© (ANDA # 078334) GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ˾Çí CYPRESS PHARM Approval 02/28/2008¿Ú·þÈÜÒº/Ö¹ÍÂÒ© (ANDA # 078957) STAVUDINE˾Ëû·ò¶¨ INVAGEN PHARMS Tentative Approval 02/28/2008½ºÄÒ/¿¹°¬×ÌÒ© (NDA # 010402)ESTROGENS, CONJUGATED¹²éî´Æ¼¤ËØ WYETH PHARMS INC Labeling Revision 02/29/2008×¢Éä¼Á/´Æ¼¤ËØÈ±·¦Ö¢ (NDA # 020591) TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDEȺ¶àÆÕÀû/άÀÅÁÃ× ABBOTT Labeling Revision 02/29/2008Ƭ¼Á£¨ER£©/¸ßѪѹ (NDA # 021229)OMEPRAZOLE MAGNESIUM°ÂÃÀÀßòþ ASTRAZENECA Package Change 02/29/2008Ƭ¼Á£¨DR£©/PPI (NDA # 021305) SODIUM IODIDE, I-131µâ»¯ÄÆ DRAXIMAGE Labeling Revision 02/29/2008½ºÄÒ/Õï¶ÏÊÔ¼Á (NDA # 021348) MIGLUSTATÃÀ¸ñÂ³ÌØ ACTELION PHARMS Labeling Revision 02/29/2008½ºÄÒ/Gaucher²¡ (NDA # 021372) PALONOSETRON HYDROCHLORIDEÑÎËáÅÁÂåŵ˾Çí HELSINN HLTHCARE Efficacy Supplement with Clinical Data to Support 02/29/2008×¢Éä¼Á/Ö¹ÍÂÒ© (NDA # 021610) OXYMORPHONE HYDROCHLORIDEÑÎËáôÇÂð·Èͪ ENDO PHARMS Manufacturing Change or Addition 02/29/2008Ƭ¼Á£¨ER£©/ÕòÍ´Ò© £¨NDA # 021992) DESVENLAFAXINE SUCCINATEçúçêËáÈ¥¼×ÎÄÀ·¨ÐÁ WYETH PHARMS INC Approval 02/29/2008Ƭ¼Á£¨ER£©/¿¹ÒÖÓôÖ¢ (NDA # 022118)FENOFIBRATE·Çŵ±´ÌØ LIFECYCLE PHARMA AS Labeling Revision 02/29/2008Ƭ¼Á/½µÖ¬Ò© (ANDA # 078381) AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE±½»ÇËá°±ÂÈµØÆ½/ÑÎËá±´ÄÇÆÕÀû KALI LABS Tentative Approval 02/29/2008½ºÄÒ/¸ßѪѹ (ANDA # 078566) GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ˹Çí WOCKHARDT USA Approval 02/29/2008×¢Éä¼Á/Ö¹ÍÂÒ© (ANDA # 078886) EFAVIRENZÒÀ·¨Î¤¶÷´Ä INVAGEN PHARMS Tentative Approval 02/29/2008Ƭ¼Á/¿¹°¬×ÌÒ© 08ÄêÈýÔÂÅú×¼µÄÒ©Æ·£¨ÉÏ£© (NDA # 050638) PENICILLIN G POTASSIUMÇàÃ¹ËØ¼Ø BAXTER HLTHCARE Labeling Revision 03/01/2008/×¢Éä¼Á/¿¹ÉúËØ (NDA # 004782) ESTROGENS, CONJUGATED¹²éî´Æ¼¤ËØ WYETH PHARMS INC Labeling Revision 03/03/2008/Ƭ¼Á/´Æ¼¤ËØÈ±·¦Ö¢ (NDA # 020527) ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE¹²éî´Æ¼¤ËØ£»´×Ëá¼×ôÇÔÐͪ WYETH PHARMS INC Labeling Revision 03/03/2008/Ƭ¼Á/´Æ¼¤ËØÈ±·¦Ö¢ (NDA # 021008) OCTREOTIDE ACETATE´×Ëá°ÂÇúëÄ NOVARTIS New or Modified Indication 03/03/2008/×¢Éä¼Á/Ö«¶Ë·Ê´óÖ¢/¿¹Ö×ÁöÒ© £¨ANDA # 078313) ESCITALOPRAM OXALATE²ÝËás-Î÷̪ÆÕÀ¼ WATSON LABS Tentative Approval 03/03/2008/Ƭ¼Á/ÒÖÓôÖ¢ (ANDA # 078639) FOMEPIZOLE¼×ßÁßò SYNERX PHARMA Approval 03/03/2008/×¢Éä¼Á/½â¶¾¼Á (ANDA # 078710) TELMISARTANÌæÃ×ɳ̹ WATSON LABS Tentative Approval 03/03/2008/Ƭ¼Á/¸ßѪѹ (NDA # 021779) ILOPROSTÒÀŵǰÁл·ËØ ACTELION PHARM Labeling Revision 03/04/2008/ÈÜÒº¼Á/·Î¶¯Âö¸ßѹ (ANDA # 077329) OCTREOTIDE ACETATE´×Ëá°ÂÇúëÄ SUN PHARM INDS Approval 03/04/2008/×¢Éä¼Á/Ö«¶Ë·Ê´óÖ¢/¿¹Ö×ÁöÒ© (ANDA # 077982) ALENDRONATE SODIUM°¢ÂØì¢ËáÄÆ APOTEX Tentative Approval 03/04/2008/Ƭ¼Á/¹ÇÖÊÊèËÉ (ANDA # 078433) GEMCITABINE HYDROCHLORIDÑÎËáE¼ªÎ÷Ëû±ö SUN PHARM INDS Tentative Approval 03/04/2008×¢Éä¼Á/¿¹Ö×Áö (NDA # 021083) SIROLIMUSÎ÷ÂÞĪ˾ WYETH PHARMS INC Labeling Revision 03/05/2008/¿Ú·þÈÜÒº/ÃâÒßÒÖÖÆ¼Á (NDA # 021548) FOSAMPRENAVIR CALCIUM¸£É³ÄÇΤ¸Æ GLAXOSMITHKLINE Labeling Revision 03/05/2008/Ƭ¼Á/¿¹AIDS (NDA # 022116) FOSAMPRENAVIR CALCIUM¸£É³ÄÇΤ¸Æ GLAXO Labeling Revision 03/05/2008/»ìÐüÒº/¿¹AIDS (ANDA # 040673) PROMETHAZINE HYDROCHLORIDEÑÎËáÒì±ûຠACTAVIS TOTOWA Approval 03/05/2008/Ƭ¼Á/¿¹¹ýÃôÒ© (ANDA # 077991) CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDEÑÎËáÎ÷ÌæÀûຣ»ÑÎËáαÂ黯¼î SANDOZ Approval 03/05/2008/Ƭ¼ÁER/¿¹¸Ððҩ (ANDA # 078276) OLMESARTAN MEDOXOMIL°ÂÃÀɳ̹õ¥ MYLAN PHARMA Tentative Approval 03/05/2008/Ƭ¼Á/½µÑ¹Ò© (NDA # 015034) MEFENAMIC ACID¼×·ÒÄÇËá SCIELE PHARMA INC Labeling Revision 03/06/2008/½ºÄÒ/NSAIDs (NDA # 020990) SERTRALINE HYDROCHLORIDEÑÎËáÉáÇúÁÖ PFIZER Labeling Revision 03/06/2008/Ƭ¼Á/ÒÖÓôÖ¢ (NDA # 021299) PAROXETINE MESYLATE¼×»ÇËáÅÁÂÞÎ÷Í¡ JDS PHARMS Labeling Revision 03/06/2008/Ƭ¼Á/ÒÖÓôÖ¢ (NDA # 021436) ARIPIPRAZOLE°¢Á¢ÅÉßò OTSUKA Labeling Revision 03/06/2008/Ƭ¼Á/¾«Éñ·ÖÁÑÖ¢ (ANDA # 078537) FOMEPIZOLE¼×ßÁßò NAVINTA LLC Approval 03/06/2008/×¢Éä¼Á/½â¶¾¼Á (NDA # 020140) LEVOLEUCOVORIN×óÑÇÒ¶Ëá SPECTRUM PHARMS Approval 03/07/2008/×¢Éä¼Á/¿¹Ö×Áö (NDA # 020829) MONTELUKAST SODIUMÃÏÂ³Ë¾ÌØÄÆ MERCK Labeling Revision 03/07/2008/Ƭ¼Á/¿¹Ïø´Ò© (NDA # 021976) DARUNAVIR ETHANOLATEµØÈðÄÇΤ TIBOTEC Labeling Revision 03/07/2008/Ƭ¼Á/¿¹AIDS (ANDA # 078465) PREDNISOLONE SODIUM PHOSPHATEÆÃÄáËÉÁúÁ×ËáÄÆ PHARM ASSOC Approval 03/07/2008/ÈÜÒº¼Á/¿¹Ñ×Ò© (ANDA # 078671) NABUMETONEÝÁ¶¡ÃÀͪ INVAGEN PHARMS Approval 03/07/2008/Ƭ¼Á/NSAIDs (BLA # 103234) EPOETIN ALFA°¢·¨ÒÀ²´Í¡ AMGEN Supplement 03/07/2008/×¢Éä¼Á/ƶѪ (BLA # 103951) DARBEPOETIN ALFA°¢·¨´ï±´²´Í¡ AMGEN Supplement 03/07/2008/×¢Éä¼Á/ƶѪ (NDA # 018936) FLUOXETINE HYDROCHLORIDEÑÎËá·úÎ÷Í¡ LILLY Labeling Revision 03/09/2008/½ºÄÒ¼Á/ÒÖÓôÖ¢ (NDA # 020675) URSODIOLÐÜÈ¥Ñõµ¨Ëá AXCAN SCANDIPHARM Package Change 03/10/2008/Ƭ¼Á/µ¨½áʯ (NDA # 021266) VORICONAZOLE·üÁ¢¿µßò PFIZER Labeling Revision 03/10/2008/»ìÐü¼Á/¿¹¾úÒ© (ANDA # 077763) CLOBETASOL PROPIONATE¶þ±ûËáÂȱ¶ËûÃ×ËÉ PERRIGO ISRAEL Approval 03/10/2008/ÅçÎí¼Á/¿¹Ñ×Ò© (ANDA # 078695) ROSIGLITAZONE MALEATEÂíÀ´ËáÂÞ¸ñÁÐͪ ROXANE Tentative Approval 03/10/2008/Ƭ¼Á/½µÌÇÒ© (NDA # 016151) METHENAMINE HIPPURATEÂíÄòËáÎÚÂåÍÐÆ· VATRING PHARMS Labeling Revision 03/11/2008/Ƭ¼Á/¿¹¾úÒ© (NDA # 018452) SULFAMETHOXAZOLE; TRIMETHOPRIM»Ç°·¼×»ùÒì¶ñßò MONARCH PHARMS Labeling Revision 03/11/2008/×¢Éä¼Á/¿¹ÉúËØ (NDA # 019111) CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREXÂȱ½ÄÇÃô-»Ç»¯¶þÒÒÏ©±½-ÒÒÏ©±½¹²¾ÛÎ¶þÇâ¿É´ýÒòͪ-»Ç»¯¶þÒÒÏ©±½-ÒÒÏ©±½¹²¾ÛÎï UCB INC Labeling Revision 03/11/2008/»ìÐü¼ÁER/¿¹¸Ððҩ(NDA # 050717) FOSFOMYCIN TROMETHAMINEÁ×Ã¹ËØ»ºÑªËá°· ZAMBON Labeling Revision 03/11/2008/»ìÐü¼Á/¿¹¾úÒ© (ANDA # 065407) TOBRAMYCIN SULFATEÁòËáÍײ¼Ã¹ËØ AKORN STRIDES Approval 03/11/2008/×¢Éä¼Á/¿¹ÉúËØ (ANDA # 065470) MINOCYCLINE HYDROCHLORIDEÑÎËáÃ×ŵ»·ËØ AUROBINDO PHARMA Approval 03/11/2008/½ºÄÒ/¿¹ÉúËØ (NDA # 017111) MOLINDONE HYDROCHLORIDEÑÎËáÂðÜáͪ ENDO PHARMS Labeling Revision 03/12/2008/½ºÄÒ/¾«Éñ·ÖÁÑÖ¢ (NDA # 020444) EPOPROSTENOL SODIUMÒÀǰÁд¼ÄÆ GLAXOSMITHKLINE Labeling Revision 03/12/2008/×¢Éä¼Á/·Î¶¯Âö¸ßѹ (ANDA # 040812) HYDROXYZINEôÇຠINVAGEN PHARMS Approval 03/12/2008/Ƭ¼Á/¿¹½¹ÂÇÒ© (ANDA # 075982) TRAMADOL HYDROCHLORIDEÑÎËáÇúÂí¶à PLIVA Control Supplement 03/12/2008/Ƭ¼Á/ÕòÍ´Ò© (ANDA # 077413) PACLITAXEL×Ïɼ´¼ PLIVA LACHEMA Approval 03/12/2008/×¢Éä¼Á/¿¹Ö×ÁöÒ© (ANDA # 077455) BUPROPION HYDROCHLORIDEÑÎËá°²·ÇËûͪ ACTAVIS Approval 03/12/2008/Ƭ¼ÁER/¿¹ÒÖÓôÒ© (NDA # 018117) TRIAMCINOLONE ACETONIDE´×ËáÇú°²Äε ABBOTT Labeling Revision 03/13/2008/ÅçÎí¼Á/¿¹Ñ×Ò© (NDA # 022047) QUETIAPINE FUMARATE¸»ÂíËáàÁòƽ ASTRAZENECA Manufacturing Change or Addition 03/13/2008/Ƭ¼ÁER/¾«Éñ·ÖÁÑÖ¢ (NDA # 050706) MEROPENEMÃÀÂÞÅàÄÏ ASTRAZENECA Labeling Revision 03/13/2008/×¢Éä¼Á/¿¹ÉúËØ (ANDA # 078564) GRANISETRON HYDROCHLORIDEÑÎËá¸ñÀ˾Çí WOCKHARDT Tentative Approval 03/13/2008/×¢Éä¼Á/Ö¹ÍÂÒ© (ANDA # 078902) PAROXETINE HYDROCHLORIDEÑÎËáÅÁÂÞÎ÷Í¡ MYLAN Approval 03/13/2008/Ƭ¼Á/¿¹ÒÖÓôÒ© (NDA # 020986) INSULIN ASPART RECOMBINANTÖØ×éÒȵºËØ NOVO NORDISK INC Patient Population Altered 03/14/2008/×¢Éä¼Á/½µÌÇÒ©(NDA # 021794) DAPSONE°±±½í¿ QLT USA Efficacy Supplement with Clinical Data to Support 03/14/2008/Äý½º¼Á/Ѱ³£ðî´¯ (ANDA # 077126) AMIFOSTINE°¢Ã׸£Í¡ SUN PHARM INDS Approval 03/14/2008/×¢Éä¼Á/¿¹Ö×Áö |
3Â¥2008-04-03 16:24:00
xiaohezi7844
½ûÑÔ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ¹ó±ö: 0.7
- ½ð±Ò: 13254.2
- É¢½ð: 275
- ºì»¨: 54
- ɳ·¢: 26
- Ìû×Ó: 8605
- ÔÚÏß: 266.7Сʱ
- ³æºÅ: 120405
- ×¢²á: 2005-11-29
- רҵ: Ò©ÎïÉè¼ÆÓëÒ©ÎïÐÅÏ¢
|
FDA08ÄêÈýÔÂÅú×¼µÄÒ©Æ·£¨Ï£© ************************* (NDA # 020409) FLUNISOLIDE·úÄáËÉ IVAX RES LLC Manufacturing Change or Addition 03/17/2008/ÅçÎí¼Á/ÉöÉÏÏÙÆ¤Öʼ¤ËØ (NDA # 022207) MORPHINE SULFATEÁòËáÂð·È ROXANE Approval 03/17/2008/Ƭ¼Á/ÕòÍ´Ò© (ANDA # 040723) ISOSORBIDE DINITRATEÏõËáÒìɽÀæõ¥ COREPHARMA Approval 03/17/2008/Ƭ¼Á£¨ER£©/ÐĽÊÍ´ (ANDA # 076128) OFLOXACINÑõ·úɳÐÇ BAUSCH AND LOMB Approval 03/17/2008/µÎ¼Á/¿¹ÉúËØ (ANDA # 076616) OFLOXACINÑõ·úɳÐÇ HI TECH PHARMA Approval 03/17/2008/µÎ¼Á/¿¹ÉúËØ (ANDA # 078222) OFLOXACINÑõ·úɳÐÇ ALCON Approval 03/17/2008/µÎ¼Á/¿¹ÉúËØ (ANDA # 078308) ONDANSETRON HYDROCHLORIDEÑÎËá°ºµ¤Ë¾Çí CLARIS LIFESCIENCES Approval 03/17/2008/×¢Éä¼Á/Ö¹ÍÂÒ© (ANDA # 077138) CIPROFLOXACIN»·±ûɳÐÇ TEVA PARENTERAL Approval 03/18/2008/×¢Éä¼Á/¿¹ÉúËØ (ANDA # 077753) CIPROFLOXACIN»·±ûɳÐÇ HOSPIRA Approval 03/18/2008/×¢Éä¼Á/¿¹ÉúËØ (ANDA # 077888) CIPROFLOXACIN»·±ûɳÐÇ BAXTER HLTHCARE Approval 03/18/2008/×¢Éä¼Á/¿¹ÉúËØ (ANDA # 078024) CIPROFLOXACIN»·±ûɳÐÇ CLARIS LIFESCIENCES Approval 03/18/2008/×¢Éä¼Á/¿¹ÉúËØ (ANDA # 078114) CIPROFLOXACIN»·±ûɳÐÇ BEDFORD Approval 03/18/2008/×¢Éä¼Á/¿¹ÉúËØ (ANDA # 078173) RIZATRIPTAN BENZOATE±½¼×ËáÀûÔúÇú̹ MYLAN PHARMA Tentative Approval 03/18/2008/¿Ú±ÀƬ/ƫͷʹ (ANDA # 078252) CIPROFLOXACIN»·±ûɳÐÇ ACS DOBFAR INFO SA Approval 03/18/2008/×¢Éä¼Á/¿¹ÉúËØ (ANDA # 078476) FOSPHENYTOIN SODIUMÁ×±½Í×Ӣį AKORN STRIDES Approval 03/18/2008/×¢Éä¼Á/¿¹ñ²ðïÒ© (NDA # 021400) VARDENAFIL HYDROCHLORIDEÑÎËá·¥µØÄÇ·Ç BAYER HLTHCARE Labeling Revision 03/19/2008/Ƭ¼Á/¿¹EDÒ© (ANDA # 040587) BENZONATATE±½×ôÄÇõ¥ SUN PHARM INDS INC Approval 03/19/2008/½ºÄÒ/Õò¿ÈÒ© (ANDA # 065441) CEFEPIME HYDROCHLORIDEÑÎËáÍ·æßßÁë¿ ACS DOBFAR Approval 03/19/2008/×¢Éä¼Á/¿¹ÉúËØ (ANDA # 077100) DIVALPROEX SODIUMË«±ûÎìËáÄÆ ZYDUS PHARMS USA Tentative Approval 03/19/2008/Ƭ¼Á£¨DR£©/¿¹ñ²ðïÒ© (NDA # 020692) SALMETEROL XINAFOATEɳÃÀÌØÂÞôÇÝÁ¼×ËáÑÎ GLAXO GRP LTD Labeling Revision 03/20/2008/·Û¼Á/ƽ´Ò© (NDA # 021223) ZOLEDRONIC ACIDßòÀ´ì¢Ëá NOVARTIS Patient Population Altered 03/20/2008/×¢Éä¼Á/¿¹Ö×ÁöÒ© (NDA # 021254) FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE±ûËá·úÌæ¿¨ËÉ£¬É³ÃÀÌØÂÞôÇÝÁ¼×ËáÑÎ GLAXOSMITHKLINE Labeling Revision 03/20/2008/ÅçÎí¼Á/ƽ´Ò© (NDA # 022056) OMEPRAZOLE/°ÂÃÀÀßò ASTRAZENECA Approval 03/20/2008/»ìÐü¼Á/PPI (NDA # 022177) STAVUDINE; LAMIVUDINE; NEVIRAPINE˾Ëû·ò¶¨/ÀÃ×·ò¶¨/ÄÎΤÀƽ STRIDES ACROLAB Tentative Approval 03/20/2008/Ƭ¼Á/¿¹°¬×ÌÒ©(NDA # 022249) BENDAMUSTINE HYDROCHLORIDEÑÎËá±½´ïĪ˾͡ CEPHALON Approval 03/20/2008/×¢Éä¼Á/°×Ѫ²¡ (ANDA # 040418) ACETAMINOPHEN; HYDROCODONE BITARTRATE¶ÔÒÒõ£°±»ù·Ó£¬ÖؾÆÊ¯ËáÇâ¿Éͪ MALLINCKRODT Control Supplement 03/20/2008/¿Ú·þÈÜÒº¼Á/ÕòÍ´Ò© (ANDA # 040535) ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE¶ÔÒÒõ£°±»ù·Ó£¬ÑÎËáÑõ¿Éͪ WATSON LABS Package Change 03/20/2008/Ƭ¼Á/ÕòÍ´Ò© (ANDA # 040813) ACETAMINOPHEN; HYDROCODONE BITARTRATE¶ÔÒÒõ£°±»ù·Ó£¬ÖؾÆÊ¯ËáÇâ¿Éͪ INTERPHARM Packager Addition 03/20/2008/Ƭ¼Á/ÕòÍ´Ò© (ANDA # 076642) HYDROCODONE BITARTRATE; IBUPROFENÖØ¾ÆÊ¯ËáÇâ¿Éͪ£¬²¼Âå·Ò INTERPHARM Packager Addition 03/20/2008/Ƭ¼Á/ÕòÍ´Ò© (ANDA # 076899) SULFAMETHOXAZOLE; TRIMETHOPRIM»Ç°·¼×¶ñßò-¼×ÑõÜÐठINTERPHARM Packager Addition 03/20/2008/Ƭ¼Á/¿¹ÉúËØ (ANDA # 077094) RIBAVIRINÀû°ÍΤÁÖ ZYDUS PHARMS USA Packaging Addition 03/20/2008/Ƭ¼Á/¿¹²¡¶¾Ò© (ANDA # 077289) CITALOPRAM HYDROBROMIDEÇâäåËáÎ÷̪ÆÕÀ¼ INTERPHARM Packager Addition 03/20/2008/Ƭ¼Á/¿¹ÒÖÓôÒ© (ANDA # 077743) RIBAVIRINÀû°ÍΤÁÖ SANDOZ Control Supplement 03/20/2008/Ƭ¼Á/¿¹²¡¶¾Ò© (ANDA # 077779) METOPROLOL SUCCINATE¾ÆÊ¯ËáÃÀÍÐÂå¶û KV PHARM Approval 03/20/2008/Ƭ¼Á£¨ER£©/½µÑ¹Ò© (ANDA # 077824) RANITIDINE HYDROCHLORIDEÑÎËáÀ×ÄáÌæ¶¡ INTERPHARM Packager Addition 03/20/2008/Ƭ¼Á/H2ÊÜÌåÞ׿¹¼Á (ANDA # 077880) METFORMIN HYDROCHLORIDEÑÎËá¶þ¼×Ë«ëÒ INTERPHARM Packager Addition 03/20/2008/Ƭ¼Á/½µÌÇÒ© (ANDA # 078149) ASPIRIN; BUTALBITAL; CAFFEINE°¢Ë¾Æ¥ÁÖ/²¼Ëû±ÈÍ×/¿§·ÈÒò MUTUAL PHARM Facility Addition 03/20/2008/½ºÄÒ/ÕòÍ´Ò© (ANDA # 089883) ACETAMINOPHEN; HYDROCODONE BITARTRATE¶ÔÒÒõ£°±»ù·Ó£¬ÖؾÆÊ¯ËáÇâ¿Éͪ WATSON LABS Manufacturing Revision 03/20/2008/Ƭ¼Á/ÕòÍ´Ò© (NDA # 020232) ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE¶ÔÒÒõ£°±»ù·Ó,²¼Ëû±ÈÍ×,¿§·ÈÒò,Á×Ëá¿É´ýÒò WATSON PHARMS Labeling Revision 03/21/2008/½ºÄÒ/ÕòÍ´Ò© (NDA # 021235) FLUOXETINE HYDROCHLORIDEÑÎËá·úÎ÷Í¡ LILLY Labeling Revision 03/21/2008/¿Ú·þÈÜÒº/¿¹ÒÖÓôÒ© (NDA # 021520) FLUOXETINE HYDROCHLORIDE; OLANZAPINEÑÎËá·úÎ÷Í¡£»°ÂµªÆ½ LILLY Labeling Revision 03/21/2008/½ºÄÒ/¿¹ÒÖÓôÒ© (ANDA # 040847) GLYCOPYRROLATE¸ñ¡äå°· INDICUS PHARMA Approval 03/21/2008/Ƭ¼Á/¿¹µ¨¼îÒ© (ANDA # 040875) PHENTERMINE HYDROCHLORIDEÑÎËá±½¶¡°· KVK TECH Approval 03/21/2008/½ºÄÒ/ʳÓûÒÖÖÆ¼Á (ANDA # 078014) ONDANSETRON HYDROCHLORIDEÑÎËá°ºµ¤Ë¾Çí TARO PHARMS IRELAND Approval 03/21/2008/×¢Éä¼Á/Ö¹ÍÂÒ© (ANDA # 078926) GABAPENTIN¼Ó°ÍÅç¶¡ ZYDUS PHARMS USA INC Tentative Approval 03/21/2008/Ƭ¼Á/¿¹ñ²ðïÒ© (NDA # 017531) TRIMETHOBENZAMIDE HYDROCHLORIDEÑÎËáÈý¼×Ñõ±½õ£°· KING PHARMS Labeling Revision 03/24/2008/½ºÄÒ/Êõºó¶ñÐÄŻ͠(NDA # 021168) DIVALPROEX SODIUMË«±ûÎìËáÄÆ ABBOTT Patient Population Altered 03/24/2008/Ƭ¼Á£¨ER£©/¿¹ñ²ðïÒ© (NDA # 021337) ERTAPENEM SODIUM¶òËûÅàÄÏÄÆ MERCK Labeling Revision 03/24/2008/×¢Éä¼Á/¿¹ÉúËØ (NDA # 021777) CYCLOBENZAPRINE HYDROCHLORIDEÑÎËá»·±½ÔúÁÖ ANESTA Labeling Revision 03/24/2008/½ºÄÒ£¨ER£©/¼¡ËÉÒ© (NDA # 022267) DIVALPROEX SODIUMË«±ûÎìËáÄÆ ABBOTT Approval 03/24/2008/Ƭ¼Á£¨ER£©/¿¹ñ²ðïÒ© (NDA # 021567) ATAZANAVIR SULFATEÁòËá°¢ÔúÄÇΤ BRISTOL MYERS SQUIBB Patient Population Altered 03/25/2008/½ºÄÒ/¿¹°¬×ÌÒ© (BLA # 125019) IBRITUMOMAB TIUXETANÒÁ¹ IDEC PHARMACEUTICALS CORP Supplement 03/25/2008/×¢Éä¼Á/¿¹Ö×ÁöÒ© (NDA # 020983) ALBUTEROL SULFATEÁòËáɳ¶¡°·´¼ GLAXOSMITHKLINEEfficacy Supplement with Clinical Data to Support 03/26/2008/ÅçÎí¼Á/Ö§Æø¹Ü¾·ÂÎ (ANDA # 065327) CEFPROZILÍ·æß±ûÏ© APOTEX INC Approval 03/26/2008/Ƭ¼Á/¿¹ÉúËØ (ANDA # 076509) FENOFIBRATE·Çŵ±´ÌØ IMPAX LABS Approval 03/26/2008/Ƭ¼Á/½µÖ¬Ò© (ANDA # 040704) BETHANECHOL CHLORIDEÂȱ´¶¡õ¥ LANNETT Approval 03/27/2008/Ƭ¼Á/½µÖ¬Ò© (NDA # 050706) MEROPENEMÃÀÂÞÅàÄÏ ASTRAZENECA Labeling Revision 03/27/2008/×¢Éä¼Á/¿¹ÉúËØ (NDA # 050726) AMOXICILLIN; CLAVULANATE POTASSIUM°¢ÄªÎ÷ÁÖ/¿ËÀάËá¼Ø GLAXOSMITHKLINE Labeling Revision 03/27/2008×¢Éä¼Á/¿¹ÉúËØ/¦Â-ÄÚõ£°·Àà/¦Â-ÄÚõ£°·Ã¸ÒÖÖÆ¼Á (NDA # 050630) CILASTATIN SODIUM; IMIPENEMÑǰ·ÅàÄÏÎ÷˾Ëû¶¡ÄÆ MERCK Labeling Revision 03/28/2008¾×½ÀƬ/¿¹ÉúËØ/¦Â-ÄÚõ£°·Àà/¦Â-ÄÚõ£°·Ã¸ÒÖÖÆ¼Á (NDA # 050761) AMOXICILLIN°¢ÄªÎ÷ÁÖ GLAXOSMITHKLINE Labeling Revision 03/28/2008/¾×½ÀƬ/¿¹ÉúËØ (ANDA # 065390) RIFAMPINÀû¸£Æ½ LANNETT Approval 03/28/2008/½ºÄÒ/¿¹ÉúËØ (ANDA # 078525) LAMOTRIGINEÀĪÈýຠTARO PHARM INDS Tentative Approval 03/28/2008/Ƭ¼Á/¿¹ñ²ðïÒ© (NDA # 021319) DUTASTERIDE¶ÈËûÐÛ°· GLAXOSMITHKLINE Labeling Revision 03/31/2008/½ºÄÒ¼Á/Á¼ÐÔǰÁÐÏÙÔöÉú£¨BPH£© (NDA # 022009) AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE°¢ÎÖ±½ËÉ/ÒÀÝ¨Êæ/°Â¿ËÁ¢ÁÖ/¶þÑõ»¯îÑ LOREAL USA Approval 03/31/2008/Èé¸àOTC/·Àɹ¼Á (NDA # 022064) LEVOCETIRIZINE DIHYDROCHLORIDEÑÎËá×óÐýÎ÷ÌæÀûຠUCB INC Labeling Revision 03/31/2008/Ƭ¼Á/H1ÊÜÌåÞ׿¹¼Á (ANDA # 040842) HYDROXYZINE HYDROCHLORIDEÑÎËáôÇÂð·Èͪ NORTHSTAR HLTHCARE Approval 03/31/2008/Ƭ¼Á/ÕòÍ´Ò© (ANDA # 078084) METRONIDAZOLE¼×Ïõßò CLARIS LIFESCIENCES Approval 03/31/2008/×¢Éä¼Á/¿¹ÑáÑõ¾úÓ뿹µÎ³æÒ© (ANDA # 040876) PHENTERMINE HYDROCHLORIDEÑÎËá±½¶¡°· NORTHSTAR HLTHCARE Approval 03/31/2008/Ƭ¼Á/ʳÓûÒÖÖÆ¼Á (NDA # 020090) FLUCONAZOLE·ú¿µßò PFIZER Labeling Revision 03/31/2008/¿Ú·þ»ìÐü¼Á/¿¹Õæ¾úÒ© |
4Â¥2008-04-03 16:24:30
jiaruohuang
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 32.9
- É¢½ð: 30
- ºì»¨: 1
- Ìû×Ó: 227
- ÔÚÏß: 5.4Сʱ
- ³æºÅ: 321401
- ×¢²á: 2007-03-10
- ÐÔ±ð: GG
- רҵ: gongyi
5Â¥2008-04-03 21:32:16













»Ø¸´´ËÂ¥
